Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2717-2721

  Li, Jinhua ^a   Bouton Verville, Hilary ^a   Holmes, Lillia M ^a   Burgin, Kelly E ^a   Jakubchak, Susan ^a   Yu, Xianzhong ^a,b   Wagner, Thomas E ^a,b   Wei, Yanzhang ^a,b  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

GM CSF; Immunotherapy; Tumor growth

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CLONE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; EXPRESSION VECTOR; FEMALE; GENETIC TRANSFECTION; GRANULOCYTOSIS; LYMPHOCYTE; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; CELL GROWTH PROCESSES; CLONE CELLS; FEMALE; GENE THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, SCID; NEOPLASMS, EXPERIMENTAL; TRANSFECTION;

EID: 6444224491     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Quesniaux VFJ and Jones TC: Granulocyte-macrophage colony stimulating factor. In: Thomson A W (eds), The Cytokine Handbook, 3rd edition, pp. 636-670. San Diego, CA: Academic Press, 1998.
2. Hamilton JA: GM-CSF in inflammation and autoimmunity. Trends in Immunol 23: 403-408, 2002.
3. Armitage JO: Emerging applications of recombinant human granulocyte-macrophage colony-stimulation factor. Blood 92: 4491-4508, 1998.
4. Dranoff G: GM-CSF-secreting melanoma vaccines. Oncogen 22: 3188-3192, 2003.
5. Chang, EY, Chen CH, Ji H, Wang TL, Hung K, Lee BP, Huang AY, Kurman RJ, Pardoll DM and Wu T: Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Int J Can 86: 725-730, 2000.
6. Toda M, Martuza RL and Rabkin SD: Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte macrophage colony-stimulating factor. Mol Ther 2: 324-329, 2000.
7. Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S and Rees RC: Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy. Prostate 56: 65-73, 2003.
8. Loudon PT, McLean CS, Martin G, Curry J, Leigh Shaw M, Hoogstrate C, Verdegaal E and Osanto S: Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma. J Gene Med 5: 407-416, 2003.
9. Couch M, Saunders JK, O'Malley BW Jr, Pardoll D and Jaffee E: Genetically engineered tumor cell vaccine in a head and neck cancer model. Laryngoscope 113: 552-556, 2003.
10. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D and Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90: 3539-3543, 1993.
11. Lumniczky K, Desaknai S, Mangel L, Szende B, Hamada H, Hidvegi E and Safrany G: Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccine in a murine glioma model. Can Gene Ther 9: 44-52, 2002.
12. Diament MJ, Stillitani MI, Puricelli L, Bal de Kier-Joffe E and Klein S: GM-CSF secreted by murine adenocarcinoma cells modulates tumor progression and immune activity. Oncol Rep 10: 1647-1652, 2004.
13. Watanabe M, Ono K, Ozeki Y, Tanaka S, Aida S and Okuno Y: Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol 28: 559-562, 1998.
14. Grote D, Cattaneo R and Fielding AK: Neutrophiles contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression. Can Res 63: 6463-6468, 2003.
15. Miller G, Pillarisetty VG, Shah AB, Lahrs S, Xing Z and DeMatteo RP: Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. J Immunol 169: 2875-2885, 2002.
16. Maini A, Nishisaka N, Kionshita Y, Jones RF, Wang CY and Haas GP: Combination of radiation and vaccination with autologous tumor cell expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinoma. In Vivo 17: 119-123, 2003.